Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic adipose-derived stem cells for complex perianal fistulas in Crohn's disease
NL-OMON32259Phase 2Withdrawn
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2008
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Crohn's disease and anal fistula (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Drug-related adverse events and Reduction in draining fistulas at 12 weeks. Planned start Apr 2008; status: withdrawn.
02
Conditions
Crohn's diseaseanal fistula
Beyond the preview
Go deeper on NL-OMON32259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32259.